At the conference last week in San Francisco, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO Marianne De Backer, who explained a bit more about what a dual-masked T-cell ...
The push to regard addiction as a disease is well-intentioned—driven by a desire to lessen stigma—but fails to account for the many facets and facts of the condition. Worse, it robs sufferers ...